Leptin - A predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes

Diabetic Medicine

Volumn 25, Issue 8, 2008, Pages 949-955

  Wallander, M ^a,c   Soderberg S ^b   Norhammar, A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abnormal glucose metabolism; Adiponectin; Diabetes mellitus; Leptin; Myocardial infarction; Prognosis

Indexed keywords

ADIPONECTIN; LEPTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; HEART FAILURE; HEART INFARCTION; HEART REINFARCTION; HORMONE BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PROGNOSIS;

ADIPONECTIN; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; LEPTIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REFERENCE VALUES; RISK FACTORS;

EID: 48149107378     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02509.x     Document Type: Article

References (33)

1. Sobel BE, Frye R, Detre KM. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation 2003 107 : 636 642.
2. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003 289 : 76 79.
3. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Rydén L et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002 359 : 2140 2144.
4. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Öhrvik J, Rydén L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2004 25 : 1990 1997.
5. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006 189 : 47 60.
6. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002 26 : 1407 1433.
7. Seufert J. Leptin effects on pancreatic beta-cell gene expression and function. Diabetes 2004 53 (Suppl. 1 S152 158.
8. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999 246 : 409 418.
9. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001 104 : 3052 3056.
10. Soderberg S, Zimmet P, Tuomilehto J, Chitson P, Gareeboo H, Alberti KG et al. Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) 2007 31 : 1126 1133.
11. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004 291 : 1730 1737.
12. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA et al. Adiponectin and development of Type 2 diabetes in the Pima Indian population. Lancet 2002 360 : 57 58.
13. Bartnik M, Malmberg K, Hamsten A, Efendic S, Norhammar A, Silveira A et al. Abnormal glucose tolerance - a common risk factor in patients with acute myocardial infarction in comparison with population-based controls. J Intern Med 2004 256 : 288 297.
14. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998 15 : 539 553.
15. ESC. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000 21 : 1502 1513.
16. Wallerstedt SM, Eriksson AL, Niklason A, Ohlsson C, Hedner T. Serum leptin and myocardial infarction in hypertension. Blood Press 2004 13 : 243 246.
17. Soderberg S, Ahren B, Stegmayr B, Johnson O, Wiklund PG, Weinehall L et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 1999 30 : 328 337.
18. Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med 2004 256 : 128 136.
19. Sierra-Johnson J, Romero-Corral A, Lopez-Jimenez F, Gami AS, Sert Kuniyoshi FH, Wolk R et al. Relation of increased leptin concentrations to history of myocardial infarction and stroke in the United States population. Am J Cardiol 2007 100 : 234 239.
20. Piatti P, Di Mario C, Monti LD, Fragasso G, Sgura F, Caumo A et al. Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting. Circulation 2003 108 : 2074 2081.
21. Couillard C, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S et al. Leptinemia is not a risk factor for ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Diabetes Care 1998 21 : 782 786.
22. Brennan AM, Li TY, Kelesidis I, Gavrila A, Hu FB, Mantzoros CS. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study. Diabetologia 2007 50 : 1178 1185.
23. Viikari LA, Huupponen RK, Viikari JS, Marniemi J, Eklund C, Hurme M et al. Relationship between leptin and C-reactive protein in young Finnish adults. J Clin Endocrinol Metab 2007 92 : 4753 4758.
24. Meisel SR, Ellis M, Pariente C, Pauzner H, Liebowitz M, David D et al. Serum leptin levels increase following acute myocardial infarction. Cardiology 2001 95 : 206 211.
25. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998 83 : 280 283.
26. McNeely MJ, Boyko EJ, Weigle DS, Shofer JB, Chessler SD, Leonnetti DL et al. Association between baseline plasma leptin levels and subsequent development of diabetes in Japanese Americans. Diabetes Care 1999 22 : 65 70.
27. Wallander M, Bartnik M, Efendic S, Hamsten A, Malmberg K, Ohrvik J et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known Type 2 diabetes: a report from the GAMI study. Diabetologia 2005 48 : 2229 2235.
28. Snijder MB, Heine RJ, Seidell JC, Bouter LM, Stehouwer CD, Nijpels G et al. Associations of adiponectin levels with incident impaired glucose metabolism and Type 2 diabetes in older men and women: the hoorn study. Diabetes Care 2006 29 : 2498 2503.
29. Schmidt MI, Duncan BB, Vigo A, Pankow JS, Couper D, Ballantyne CM et al. Leptin and incident Type 2 diabetes: risk or protection? Diabetologia 2006 49 : 2086 2096.
30. Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003 23 : 85 89.
31. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in Type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000 20 : 1595 1599.
32. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002 106 : 2767 2770.
33. Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y et al. Adiponectin and coronary heart disease: the Strong Heart Study. Arterioscler Thromb Vasc Biol 2005 25 : e15 16.